Purple (PRPL) Q1 2026 earnings review
Accounting Noise and Margin Compression Mask Turnaround Progress
Purple's Q1 results offer a conflicting narrative. Total amounts billed dropped a modest 3.4%, but a forced accounting adjustment for wholesale transactions knocked reported revenue down 8.1% to $95.7 million. While management praised improving consistency and a 7.0% comparable sales jump in showrooms, profitability told a darker story. Gross margins collapsed to 36.8%, and the net loss widened by 60% to $30.5 million. Despite starting the year with a $4.8 million Adjusted EBITDA loss, the company defiantly held its full-year EBITDA target of $20-$30 million.
🐂 Bull Case
Showroom comparable sales jumped 7.0%, delivering a third straight quarter of positive growth. When consumers physically experience the product, conversion rates rise.
Despite mechanically lowering its revenue outlook due to accounting changes, Purple maintained its $20-$30 million Adjusted EBITDA guidance, reflecting high confidence in back-half cost efficiencies.
🐻 Bear Case
Gross margin fell 260 basis points to 36.8%. The costs of rolling out floor models and weak manufacturing absorption are severely hampering unit economics.
Net loss ballooned to $30.5 million, exacerbated by $4.3 million drained into an ongoing, unresolved strategic alternatives review.
⚖️ Verdict: ⚪
Neutral. The optical top-line miss is mostly accounting noise, and the showroom growth is a strong proof of concept. However, reversing margins and mounting net losses create too much friction to turn bullish until the H2 inflection materializes.
Key Themes
Margin Collapse Contradicts Execution Narrative
Management touted 'more disciplined execution,' but profitability metrics are flashing red. Gross margin reversed sharply, dropping from 39.4% last year to 36.8%. This compression was driven by manufacturing deleverage and heavy investments in floor models for Mattress Firm. If volume does not accelerate soon, this fixed-cost burden will continue to crush profitability.
E-commerce Headwinds Highlight Macro Softness
While management noted sequential improvement online, the e-commerce channel remains a persistent drag on the business. Combined with lower wholesale demand, this reflects a broader macroeconomic challenge: consumers are still delaying high-ticket, discretionary home purchases. Until the macro environment thaws, digital acquisition costs will likely remain elevated relative to conversion rates.
Wholesale Accounting Noise Obscures Real Demand
A new 'net reporting' requirement for certain wholesale transactions forced Purple to slash its FY26 revenue guidance by $35 million at the midpoint. In Q1 alone, this accounting change erased $4.9 million from reported revenue. While the company insists this does not impact EBITDA, the lack of clean top-line visibility adds an unnecessary layer of complexity for investors trying to gauge actual market share.
Premium Tech Validation via Purple Royale
The 'Path to Premium Sleep' strategy is taking root. The early traction of the new Purple Royale line at Mattress Firm, combined with continued momentum for the Rejuvenate 2.0 collection, proves that the proprietary GelFlex Grid technology commands a premium. Shifting the product mix away from low-end, highly promotional mattresses is the company's strongest lever for long-term margin expansion.
Showroom Traffic Conversion
Physical retail remains Purple's strongest asset. Showroom comparable sales grew an impressive 7.0%, marking the third consecutive quarter of positive comps. When consumers can actually feel the product, conversion rates and average order values spike. This channel resilience is a critical buffer against the softer e-commerce landscape.
Strict Operating Expense Discipline
Despite the top-line pressures, management is maintaining strict control over overhead. Operating expenses fell 6.3% YoY to $52.0 million. This structural cost reduction, stemming from prior restructuring actions, is the primary reason Adjusted EBITDA remained flat YoY despite the significant gross margin hit.
Strategic Review Overhang
The ongoing evaluation of strategic alternatives is becoming expensive. Q1 operating expenses included $4.3 million in strategic alternative costs. Until a decision is finalized, this process will continue to drain cash and distract from core operations.
Other KPIs
Down 2.7% sequentially from December 2025. Keeping inventory lean is a positive indicator that management is reacting appropriately to choppy demand while navigating the Mattress Firm rollout.
Stable compared to the $24.3 million at year-end 2025. Liquidity remains tight but sufficient for current operations, though it is heavily reliant on the underlying debt structure.
Guidance
Stable. The company lowered this range from the prior $500-$520 million, but solely due to the new net reporting requirement for wholesale transactions. Operationally, this implies roughly flat revenue year-over-year compared to FY25.
Accelerating. The company maintained this outlook despite the optical top-line cut. Achieving the $25.0 million midpoint after starting Q1 at a $4.8 million loss requires a massive, rapid inflection in profitability over the next three quarters.
Key Questions
EBITDA Bridge Feasibility
With Q1 printing a $4.8 million Adjusted EBITDA loss, what specific operational levers will drive the massive sequential acceleration required to hit the $20-$30 million full-year guidance?
Margin Drag Duration
How much longer will the strategic investments in Royale floor models drag down gross margins, and when do you expect margins to return to the 40%+ level seen in late 2025?
Strategic Review Timeline
Given the $4.3 million incurred in Q1 for the strategic alternatives review, is there a hard deadline for the Board to conclude this process and stem the cash bleed?
Accounting Adjustment Mechanics
Does the $4.9 million quarterly revenue reduction from the new net reporting requirement carry any actual cash or margin implications, or is it purely optical?